Calypte Biomedical Corporation (OTCBB: CBMC)
On Oct. 13th, the company announced that it has received an order for 50,000 tests of its Aware(TM) HIV-1/2 OMT product from LifeLine Scientific, its newly appointed distributor for the UAE and several other countries in the region. The purchase is the first large order resulting from a newly implemented sales initiative.
Visit Wall Street News Alert
Monday, October 13, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment